JP2023155245A5 - - Google Patents

Download PDF

Info

Publication number
JP2023155245A5
JP2023155245A5 JP2023125566A JP2023125566A JP2023155245A5 JP 2023155245 A5 JP2023155245 A5 JP 2023155245A5 JP 2023125566 A JP2023125566 A JP 2023125566A JP 2023125566 A JP2023125566 A JP 2023125566A JP 2023155245 A5 JP2023155245 A5 JP 2023155245A5
Authority
JP
Japan
Prior art keywords
seq
nucleic acid
acid molecule
vaccine
separated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023125566A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023155245A (ja
JP7659599B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2018/065529 external-priority patent/WO2019118766A2/en
Application filed filed Critical
Publication of JP2023155245A publication Critical patent/JP2023155245A/ja
Publication of JP2023155245A5 publication Critical patent/JP2023155245A5/ja
Priority to JP2025056239A priority Critical patent/JP2025092647A/ja
Application granted granted Critical
Publication of JP7659599B2 publication Critical patent/JP7659599B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023125566A 2017-12-13 2023-08-01 サバイビンを標的とするがんワクチンおよびその使用 Active JP7659599B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025056239A JP2025092647A (ja) 2017-12-13 2025-03-28 サバイビンを標的とするがんワクチンおよびその使用

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762598267P 2017-12-13 2017-12-13
US62/598,267 2017-12-13
PCT/US2018/065529 WO2019118766A2 (en) 2017-12-13 2018-12-13 Cancer vaccines targeting survivin and uses thereof
JP2020532715A JP7385569B2 (ja) 2017-12-13 2018-12-13 サバイビンを標的とするがんワクチンおよびその使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020532715A Division JP7385569B2 (ja) 2017-12-13 2018-12-13 サバイビンを標的とするがんワクチンおよびその使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025056239A Division JP2025092647A (ja) 2017-12-13 2025-03-28 サバイビンを標的とするがんワクチンおよびその使用

Publications (3)

Publication Number Publication Date
JP2023155245A JP2023155245A (ja) 2023-10-20
JP2023155245A5 true JP2023155245A5 (https=) 2024-03-06
JP7659599B2 JP7659599B2 (ja) 2025-04-09

Family

ID=66734396

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020532715A Active JP7385569B2 (ja) 2017-12-13 2018-12-13 サバイビンを標的とするがんワクチンおよびその使用
JP2023125566A Active JP7659599B2 (ja) 2017-12-13 2023-08-01 サバイビンを標的とするがんワクチンおよびその使用
JP2025056239A Pending JP2025092647A (ja) 2017-12-13 2025-03-28 サバイビンを標的とするがんワクチンおよびその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020532715A Active JP7385569B2 (ja) 2017-12-13 2018-12-13 サバイビンを標的とするがんワクチンおよびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025056239A Pending JP2025092647A (ja) 2017-12-13 2025-03-28 サバイビンを標的とするがんワクチンおよびその使用

Country Status (11)

Country Link
US (2) US12064473B2 (https=)
EP (1) EP3723793A4 (https=)
JP (3) JP7385569B2 (https=)
KR (2) KR102648079B1 (https=)
CN (1) CN111479583A (https=)
AU (2) AU2018383664B2 (https=)
BR (1) BR112020011820A2 (https=)
CA (1) CA3083534A1 (https=)
MX (2) MX2020006285A (https=)
RU (1) RU2751253C1 (https=)
WO (1) WO2019118766A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102648079B1 (ko) * 2017-12-13 2024-03-18 이노비오 파마수티컬즈, 인크. 서바이빈을 표적으로 하는 암 백신 및 이의 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1152402A (en) 2000-10-04 2002-04-15 Univ Pennsylvania Highly expressible genes
US20110223187A1 (en) * 2010-02-15 2011-09-15 Vafa Shahabi Live listeria-based vaccines for central nervous system therapy
AU2013243948A1 (en) * 2012-04-02 2014-10-30 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins associated with human disease
DK3122375T3 (da) * 2014-03-28 2021-05-25 Univ Washington Through Its Center For Commercialization Vacciner mod bryst- og ovariecancer
RU2749113C2 (ru) * 2015-04-22 2021-06-04 Куревак Аг Содержащая рнк композиция для лечения опухолевых заболеваний
WO2016179573A1 (en) * 2015-05-07 2016-11-10 H. Lee Moffitt Cancer Center And Research Institute, Inc. Variant survivin vaccine for treatment of cancer
US20180305702A1 (en) * 2015-09-15 2018-10-25 Advaxis, Inc. Listeria-Based Immunogenic Compositions And Methods Of Use Thereof in Cancer Prevention And Treatment
KR102648079B1 (ko) * 2017-12-13 2024-03-18 이노비오 파마수티컬즈, 인크. 서바이빈을 표적으로 하는 암 백신 및 이의 용도

Similar Documents

Publication Publication Date Title
CN105944097B (zh) 短肽作为疫苗佐剂的应用及疫苗
JP2020530765A5 (https=)
JP2008056679A5 (https=)
JP7808695B2 (ja) タンパク質発現のためのｍＲＮＡ及びそのための鋳型
JP2016539946A5 (https=)
JP2014519817A5 (https=)
JP2023155245A5 (https=)
JP2017522326A5 (https=)
CN116603068B (zh) 一种多肽疫苗递送载体及其制备方法
JP2020502075A5 (https=)
JP2005512518A5 (https=)
WO2018037246A4 (en) Immunogenic composition
RU2011120447A (ru) Эпитопные пептиды rab6kifl/kif20a и содержащие их вакцины
JP2020530453A5 (https=)
CN109415410B (zh) 靶向树突细胞的肽、利用了该肽的肽融合体、及利用了该肽融合体的疫苗
JPWO2017096432A5 (https=)
JP2011514167A5 (https=)
BR112020023354A2 (pt) vacina de peptídeo reverso
RU2019113940A (ru) Мозаичные вакцины от вируса ящура серотипа а
CN107624117A (zh) 基于乙型肝炎核心抗原的疫苗
RU2005101744A (ru) Последовательность днк и получение аллергена пыльцы трав ph1 p4 с помощью рекомбинантных способов
CN105169387A (zh) 一种用于弓形虫感染预防的免疫疫苗
JP2002510496A (ja) 細胞傷害性ｔ細胞を誘導するための医薬
CN103483441A (zh) 恒河猴ny-eso-1蛋白、其编码基因及应用
JP2006501166A5 (https=)